356 related articles for article (PubMed ID: 28951335)
1. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
3. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
4. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
8. Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.
Richter B; Hemmingsen B; Metzendorf MI; Takwoingi Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012661. PubMed ID: 30371961
[TBL] [Abstract][Full Text] [Related]
9. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
Janghorbani M; Amini M
Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
[TBL] [Abstract][Full Text] [Related]
10. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
Jadhakhan F; Marshall T; Ryan R; Gill P
BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
[TBL] [Abstract][Full Text] [Related]
11. Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.
Han SJ; Kim HJ; Kim DJ; Lee KW; Cho NH
Diabetes Res Clin Pract; 2017 Jan; 123():173-180. PubMed ID: 28043048
[TBL] [Abstract][Full Text] [Related]
12. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
[TBL] [Abstract][Full Text] [Related]
13. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
[TBL] [Abstract][Full Text] [Related]
15. One-hour post-load plasma glucose level during the OGTT predicts dysglycemia: Observations from the 24year follow-up of the Israel Study of Glucose Intolerance, Obesity and Hypertension.
Bergman M; Chetrit A; Roth J; Jagannathan R; Sevick M; Dankner R
Diabetes Res Clin Pract; 2016 Oct; 120():221-8. PubMed ID: 27596059
[TBL] [Abstract][Full Text] [Related]
16. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile.
Sesti G; Fiorentino TV; Succurro E; Perticone M; Arturi F; Sciacqua A; Perticone F
Acta Diabetol; 2014 Dec; 51(6):927-32. PubMed ID: 24619654
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
Khaleeli AA; Johnson JN; Taylor WH
Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
[TBL] [Abstract][Full Text] [Related]
18. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose.
Fiorentino TV; Marini MA; Andreozzi F; Arturi F; Succurro E; Perticone M; Sciacqua A; Hribal ML; Perticone F; Sesti G
J Clin Endocrinol Metab; 2015 Oct; 100(10):3744-51. PubMed ID: 26274345
[TBL] [Abstract][Full Text] [Related]
19. [Characteristics of the daily blood glucose profiles of impaired glucose tolerance and type 2 diabetes mellitus subjects by continuous glucose monitoring system].
Wang XL; Lu JM; Pan CY; Mu YM; Dou JT; Ba JM
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):674-7. PubMed ID: 16681924
[TBL] [Abstract][Full Text] [Related]
20. Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Manell H; Staaf J; Manukyan L; Kristinsson H; Cen J; Stenlid R; Ciba I; Forslund A; Bergsten P
J Clin Endocrinol Metab; 2016 Mar; 101(3):1181-9. PubMed ID: 26745255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]